Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033

Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A7629

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Anti-Tuberculosis Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Disease Type
    6.1    Active TB
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Latent TB
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Others
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Diagnosis and Treatment
    7.1    Diagnosis
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Blood Tests
           7.1.2.2 Imaging Tests
           7.1.2.3 Sputum Tests
           7.1.2.4 Others
        7.1.3 Market Forecast
    7.2    Treatment
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 First-Line of Drugs
              7.2.2.1.1 Major Types
                 7.2.2.1.1.1 Isoniazid
                 7.2.2.1.1.2 Ethambutol
                 7.2.2.1.1.3 Rifampin
                 7.2.2.1.1.4 Others
           7.2.2.2 Second-Line of Drugs
              7.2.2.2.1 Major Types
                 7.2.2.2.1.1 Thiacetazone
                 7.2.2.2.1.2 Paraaminosalicyclic Acid (PAS)
                 7.2.2.2.1.3 Others
           7.2.2.3 Others
        7.2.2 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Specialty Clinics
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Homecare
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  Drivers, Restraints, and Opportunities
    10.1    Overview
    10.2    Drivers
    10.3    Restraints
    10.4    Opportunities
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    F. Hoffmann-La Roche Ltd. 
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 SWOT Analysis
        14.3.2    Lannett Company Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Lupin Limited
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Macleods Pharmaceuticals Limited
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Otsuka Pharmaceutical Co. Ltd
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

​Figure 1: Global: Anti-Tuberculosis Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Anti-Tuberculosis Therapeutics Market: Breakup by Disease Type (in %), 2024
Figure 5: Global: Anti-Tuberculosis Therapeutics Market: Breakup by Diagnosis and Treatment (in %), 2024
Figure 6: Global: Anti-Tuberculosis Therapeutics Market: Breakup by End User (in %), 2024
Figure 7: Global: Anti-Tuberculosis Therapeutics Market: Breakup by Region (in %), 2024
Figure 8: Global: Anti-Tuberculosis Therapeutics (Active TB) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Anti-Tuberculosis Therapeutics (Active TB) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Anti-Tuberculosis Therapeutics (Latent TB) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Anti-Tuberculosis Therapeutics (Latent TB) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Anti-Tuberculosis Therapeutics (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Anti-Tuberculosis Therapeutics (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Anti-Tuberculosis Therapeutics (Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Anti-Tuberculosis Therapeutics (Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Anti-Tuberculosis Therapeutics (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Anti-Tuberculosis Therapeutics (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Anti-Tuberculosis Therapeutics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Anti-Tuberculosis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Anti-Tuberculosis Therapeutics (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Anti-Tuberculosis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Anti-Tuberculosis Therapeutics (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Anti-Tuberculosis Therapeutics (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Anti-Tuberculosis Therapeutics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Anti-Tuberculosis Therapeutics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: North America: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: North America: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: United States: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: United States: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Canada: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Canada: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Asia-Pacific: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Asia-Pacific: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: China: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: China: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Japan: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Japan: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: India: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: India: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: South Korea: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: South Korea: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Australia: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Australia: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Indonesia: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Indonesia: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Others: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Others: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Europe: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Europe: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Germany: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Germany: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: France: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: France: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: United Kingdom: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: United Kingdom: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Italy: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Italy: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Spain: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Spain: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Russia: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Russia: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Latin America: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Latin America: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Brazil: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Brazil: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Mexico: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Mexico: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Middle East and Africa: Anti-Tuberculosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Middle East and Africa: Anti-Tuberculosis Therapeutics Market: Breakup by Country (in %), 2024
Figure 74: Middle East and Africa: Anti-Tuberculosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Global: Anti-Tuberculosis Therapeutics Industry: Drivers, Restraints, and Opportunities
Figure 76: Global: Anti-Tuberculosis Therapeutics Industry: Value Chain Analysis
Figure 77: Global: Anti-Tuberculosis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-Tuberculosis Therapeutics Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Anti-Tuberculosis Therapeutics Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
Table 3: Global: Anti-Tuberculosis Therapeutics Market Forecast: Breakup by Diagnosis and Treatment (in Million USD), 2025-2033
Table 4: Global: Anti-Tuberculosis Therapeutics Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Anti-Tuberculosis Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Anti-Tuberculosis Therapeutics Market: Competitive Structure
Table 7: Global: Anti-Tuberculosis Therapeutics Market: Key Players

Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials